CHEK1 and cancer: Further, since previous evidence pointed toward DNA damage and repair mechanisms as other potential mediators of DSF-Cu++ anti-cancer activity, our study also tried to encompass a number of targets involved in these pathways, such as H2AX, CHK-1 and phospho-CHK-1 [14].